Guidance
Surveillance of 4CMenB vaccination to protect individuals at higher risk of gonorrhoea
National surveillance of targeted 4CMenB vaccination to protect individuals at higher risk of gonorrhoea infection in England.
Applies to England
Documents
Details
This document includes information on:
- surveillance objectives
- the targeted 4CMenB programme vaccinating against gonorrhoea
- Gonorrhoea surveillance in England
- Monitoring of antimicrobial resistance in gonorrhoea
- patient information
- monitoring the 4CMenB programme targeting gonorrhoea
- service evaluation in participating clinics
- 4CMenB vaccination impact on the characteristics of gonococcal isolates
- dissemination of information and outputs
Updates to this page
Published 13 November 2025